ESLA peer analysis
ESLA (ESLA) against its competitors: price, today's move, 1-year return and market value side by side.
- ESLA's peers: ATOS (Atossa Therapeutics), EXOZ (eXoZymes), GLSI (Greenwich LifeSciences), IMMX (Immix Biopharma), ONCY (Oncolytics Biotech), SRZN (Surrozen), TIL (Instil Bio), TLSA (Tiziana Life Sciences).
ESLA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ATOS Atossa Therapeutics | $1.65 | -5.71% | -85.59% | $16.47M |
| EXOZ eXoZymes | $3.38 | -1.46% | -77.85% | $31.91M |
| GLSI Greenwich LifeSciences | $20.00 | 1.06% | 146.00% | $293.56M |
| IMMX Immix Biopharma | $6.96 | -1.14% | 64.54% | $583.33M |
| ONCY Oncolytics Biotech | $0.39 | -11.29% | -62.44% | $53.18M |
| SRZN Surrozen | $28.41 | -7.37% | 110.44% | $212.43M |
| TIL Instil Bio | $5.55 | 2.21% | -54.51% | $37.64M |
| TLSA Tiziana Life Sciences | $0.68 | -16.43% | -60.02% | $86.50M |
| TVGN Tevogen Bio | $6.30 | 2.61% | -69.20% | $26.23M |
| ESLA Estrella Immunopharma | $0.32 | -5.73% | -81.66% | $14.11M |